• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US SIG C/R POROCOAT FEM RT SZ 4; SIGMA KNEE PRIMARY : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US SIG C/R POROCOAT FEM RT SZ 4; SIGMA KNEE PRIMARY : KNEE FEMORAL Back to Search Results
Model Number 94-0024
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Calcium Deposits/Calcification (1758); Pain (1994); Synovitis (2094); Discomfort (2330); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 02/03/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Clinical adverse event received for heterotopic bone in suprapatellar pouch : pain, severe.Event is serious and is considered moderate.Event is definitely not related to device and is possibly related to procedure.Date of implantation: (b)(6) 2020; date of event (onset): (b)(6) 2021; (right knee).Treatment: arthrotomy with ostectomy of heterotopic bone.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H6 clinical code: appropriate term / code not available (e2402) is used to capture musculoskeletal system (e16).If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H6 clinical code: removed code for appropriate term/ code not available (e2402) which captures heterotropic ossification and replaced with calcification (e230901).
 
Event or Problem Description
On (b)(6) 2020, the patient underwent bilateral primary knee arthroplasty to address osteoarthritis.Depuy products and cement were utilized in both knees.There were no indicated intra-operative complications.On (b)(6) 2021, the patient presented for a bilateral knee evaluation.In the right knee, the patient was experiencing pain, discomfort, swelling, and a palpable pop when going from flexion to extension.On (b)(6) 2021, the patient underwent a right knee arthrotomy with ostectomy of heterotopic bone of dorsal femur.The surgeon noted a significant amount of crepitus under the extensor mechanism of the right knee.The surgeon also noted excising moderate hypertrophic synovitis.No products were revised.There were no indicated intra-operative complications.On (b)(6) 2021, the patient presented for a post-operative evaluation of the right knee.The patient was noted to be doing very well with no issues.
 
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: added: h6.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected g3 awareness date of follow up # 1 to (b)(6) 2021, since it was reported in error.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).Where the product and lot code was provided, a manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIG C/R POROCOAT FEM RT SZ 4
Common Device Name
SIGMA KNEE PRIMARY : KNEE FEMORAL
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key11516718
Report Number1818910-2021-05453
Device Sequence Number14434519
Product Code MBH
UDI-Device Identifier10603295223481
UDI-Public10603295223481
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K062654
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source health professional,study
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date (Section B) 03/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number94-0024
Device Catalogue Number940024
Device Lot NumberJ50C49
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/05/2021
Supplement Date Received by Manufacturer03/22/2021
03/11/2021
03/22/2021
05/03/2021
Initial Report FDA Received Date03/18/2021
Supplement Report FDA Received Date03/30/2021
04/05/2021
04/06/2021
05/03/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DEPUY CMW 2 20G; MBT CEM KEEL TIB TRAY SZ4; PFC*SIGMA/OV/DOME PAT 3PEG,38; SIG C/R POROCOAT FEM RT SZ 4; SIG RP AOX CRV INS SZ4 12.5; DEPUY CMW 2 20G; MBT CEM KEEL TIB TRAY SZ4; PFC SIGMA/OV/DOME PAT 3PEG,38; SIG C/R POROCOAT FEM RT SZ 4; SIG RP AOX CRV INS SZ4 12.5
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
Patient Weight95
-
-